Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma. - Wikidata - awgldk - TriplyDB

Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.

Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.

http://www.wikidata.org/entity/Q41251561

about

Cabozantinib for progressive metastatic medullary thyroid cancer: a review SIFORM: shared informative factor models for integration of multi-platform bioinformatic data.Clinical characteristics and molecular pathology of skull ectopic thyroid cancer.The Role of STAT3 in Thyroid Cancer.Thyroid dysfunctions induced by tyrosine kinase inhibitors.Novel therapies for thyroid cancer.Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer.2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma.Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.Molecular pathways associated with aggressiveness of papillary thyroid cancer A young man with cough, fever and epigastric pain.PKM2 functions as a potential oncogene and is a crucial target of miR-148a and miR-326 in thyroid tumorigenesis.

P2860

Q26851709-86E49B6B-4960-4B1F-AB12-A8C58FAC219E Q31112697-3D6E54AD-25E3-4BE4-9CEE-26F7FC6C0AC4 Q37570368-561D5A3F-9412-4C70-B10F-0EF89DB60330 Q37693498-6F40DDD3-7F5B-4735-900E-4BA672C76EC2 Q38211342-0C548C90-F7B8-4BFF-8109-6E57E220E3AE Q38260495-52617F18-85A0-4D72-B92A-61C3A99E306A Q38625034-BEC3AA6D-1C79-453C-A01D-47459F92FD33 Q38848483-9786C9E5-D42A-4411-9FB9-C322B5D41022 Q38931460-93DB7163-F3E8-474C-A5A1-02C77F41C2E4 Q38960074-C7863D33-8CF2-443C-AE6E-E19ECF28DA80 Q39171721-924AD710-FE12-487F-8F2F-E83F912A8A58 Q40207995-D0173182-B1DA-4F12-92E8-776AD75EE74B Q55712018-F8A22E28-B61D-407D-96CC-13D9863645AD

P2860

Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.

http://www.wikidata.org/entity/Q41251561

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Cellular signaling pathway alt ...... r medullary thyroid carcinoma.

@en

type

label

Cellular signaling pathway alt ...... r medullary thyroid carcinoma.

@en

prefLabel

Cellular signaling pathway alt ...... r medullary thyroid carcinoma.

@en

P1433

Q41251561-E5BD81F7-B370-4E35-AA27-BB417C06EC04

P1476

Q41251561-47E8CD4A-52FD-4BE2-B8C9-1DB2B613755E

P2093

Q41251561-4DB90D73-4C0C-41CB-B825-D42DC6850D32

Q41251561-A695532E-FCD0-41F6-BB21-9BE37770B704

Q41251561-AAEA17DA-B69F-45DE-8305-0122BBEEC3A3

Q41251561-BC592A38-A649-4F49-8B7A-5C568CCC3143

P2860

Q41251561-02A48503-FF98-4A2F-A009-E734840F3AAD

Q41251561-03D9D82A-666E-4876-971A-F359208618F7

Q41251561-06958A1D-45B3-4DFD-8177-A9D15893A971

Q41251561-0784B20B-2637-48F0-B3F3-7345F4819AD2

Q41251561-096F28FD-3DA9-452B-AF1B-210FF1418798

Q41251561-0AB4A27D-50C9-4C6F-AED6-97BB02EE8515

Q41251561-0E4A07DF-50B8-4671-A04B-218C2DFFDEA7

Q41251561-17753C76-820B-4E81-A5D8-F3327F7E9ABE

Q41251561-20677641-6AC4-460B-A964-D9FBFE7CCE9F

Q41251561-25069CDC-BD29-41EE-B432-5294BAD64BC8

P304

Q41251561-A03EC12A-D16C-497B-B068-88D3563F3FA2

P31

Q41251561-292AC624-4627-4534-987B-F0F5815D0F1D

P356

Q41251561-8B21E91E-39AA-4268-9C88-8B27AC3097D9

P478

Q41251561-74AFB723-7D8D-4B13-A677-D4B19740AB87

P50

Q41251561-16B4BD12-54D4-45FD-89BC-B31C00453A68

Q41251561-304EEE4E-0F73-4BF0-874B-8583290CB296

P577

Q41251561-8343FC15-4045-452E-BBAF-4453E01316A9

P5875

Q41251561-B5AB7C93-571A-4581-84D0-E88C9903E97D

P698

Q41251561-00EA98A3-C74F-4465-BCCA-062FB2E78366

P932

Q41251561-21B645B0-086F-4C74-A7B1-10592AE8FF7C

P356

P1433

International journal of endocrinology

P1476

Cellular signaling pathway alt ...... r medullary thyroid carcinoma.

@en

P2093

Alessandro Antonelli

http://www.w3.org/2001/XMLSchema#string

Andrea Amorosi

http://www.w3.org/2001/XMLSchema#string

Libero Santarpia

http://www.w3.org/2001/XMLSchema#string

Serena Giunti

http://www.w3.org/2001/XMLSchema#string

P2860

The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

Anti-tumor activity of motesanib in a medullary thyroid cancer model.

AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines

The GDNF family: signalling, biological functions and therapeutic value

The biology and clinical relevance of the PTEN tumor suppressor pathway

Cancer phenomics: RET and PTEN as illustrative models

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

Tumor angiogenesis

PI3K pathway alterations in cancer: variations on a theme

P304

803171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/803171

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Libero Santarpia

P577

2013-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236061862

http://www.w3.org/2001/XMLSchema#string

P698

23509459

http://www.w3.org/2001/XMLSchema#string

P932

3594951

http://www.w3.org/2001/XMLSchema#string